¿Es butylene glycol dicaprylate/dicaprate seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
Pregnancy-safe products containing butylene glycol dicaprylate/dicaprate









Related ingredients
Frequently asked questions
- ¿Es butylene glycol dicaprylate/dicaprate seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive restriction found for butylene glycol dicaprylate/dicaprate. No peer‑reviewed evidence of developmental or reproductive toxicity specific to this ingredient was identified in the regulatory literature; esters of medium‑chain fatty acids and glycols are not classically associated with teratogenicity. Dermal cosmetic use implies low but measurable percutaneous exposure for adults (CosIng / PubChem show cosmetic use as emollient), so exposure scored as low. Sources checked: ECHA Annex VI (no harmonised H360/H361), CosIng, PubChem, CIR (no safety flag).
- ¿Es butylene glycol dicaprylate/dicaprate seguro durante la lactancia?
- No evidence of lactation/transfer concerns or reproductive toxicity in available regulatory/peer review sources. Given low dermal absorption from topical esters, maternal systemic exposure from cosmetic use is expected to be low; no data for milk transfer were found.
- ¿Es butylene glycol dicaprylate/dicaprate seguro para la piel del bebé?
- No infant‑specific reproductive or developmental hazards identified. Because infant skin has higher surface‑area‑to‑weight and an immature barrier, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2). Ingredient is used as an emollient/skin conditioning agent (CosIng/PubChem) with no infant‑specific restrictions identified.
- ¿Cómo puntúa VeriMom a butylene glycol dicaprylate/dicaprate?
- VeriMom puntúa butylene glycol dicaprylate/dicaprate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a butylene glycol dicaprylate/dicaprate en el embarazo?
- Consulta nuestra lista de alternativas seguras a butylene glycol dicaprylate/dicaprate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.